Home › Compare › JGSMY vs ABBV
JGSMY yields 1.98% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 1
Combined, JGSMY + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JGSMY + ABBV for your $10,000?
JG Summit Holdings, Inc. engages in consumer foods, agro-industrial and commodity food products, real property development, hotels, banking and financial services, telecommunications, petrochemicals, air transportation, and power distribution businesses. Its Foods, Agro-Industrial and Commodities segment is involved in the manufacture of snack foods, granulated and pre-mixed coffee, chocolates, candies, biscuits, instant noodles, ice cream and frozen novelties, pasta and tomato-based products, and canned beans; raising hogs and chickens; manufacture and distribution of animal feeds, corn products, and vegetable oils; synthesis of veterinary compounds; sugar milling and refining; and flour milling. The company's Air Transportation segment offers passenger and cargo air transport services. Its Real Estate and Hotels segment owns, develops, leases, and manages shopping malls and retail developments; owns and operates hotels in the Philippines; develops, sells, and leases office condominium space in office buildings and high rise residential condominiums; develops land into residential subdivisions; sells subdivision lots and residential houses; and provides customer financing. The company's Petrochemicals segment manufactures and sells polyethylene and polypropylene, polymer grade ethylene and propylene, partially hydrogenated pyrolysis gasoline, pyrolysis fuel oil, aromatics, butadiene, and liquefied petroleum gas. Its Banking segment offers commercial banking services, such as deposit-taking, lending, foreign exchange dealing, and fund transfers or remittance servicing. The company's Other Supplementary Businesses segment provides asset management, insurance brokering, foreign exchange, and securities dealing services. It operates in the Philippines, Thailand, Malaysia, Indonesia, China, Hong Kong, Singapore, Vietnam, and Myanmar. The company was founded in 1957 and is headquartered in Pasig City, the Philippines.
Full JGSMY Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.